Drug Delivery Systems Market Share, Industry Analysis [2031]

Report Description

The global drug delivery systems market size was valued at USD 40.2 Bn in 2022 and is likely to reach USD 76.2 Bn by 2031, expanding at a CAGR of 8% during 2023–2031. The market growth is driven by the rising prevalence of chronic diseases, and increasing research and development in the healthcare sector.

A drug delivery system is known as a technology or method used to deliver therapeutic substances, such as medications or drugs, to specific sites within the body. The goal of drug delivery systems is to optimize the delivery of drugs, ensuring that they reach their intended targets in sufficient concentrations while minimizing side effects and maximizing therapeutic benefits.

Get Free Sample Report

Drug delivery systems involve a range of technologies designed to transport medications into or throughout the body, utilizing various methods of administration, such as oral ingestion of pills or injection of vaccines. A drug delivery system is a mechanism that facilitates the administration of drugs into the body, enhancing their effectiveness and safety by regulating the timing, location, and rate of drug release.

These systems encompass drug delivery devices that do not contain drugs themselves, such as auto-injectors, jet-injectors, and syringes. Manufacturers producing drug delivery systems typically distribute their products to pharmaceutical companies or end-users through various pharmacy channels, including retail pharmacies, hospital pharmacies, and online pharmacies.

These systems enable precise control over the release of medications, ensuring optimal drug concentrations at the target site. This enhances the effectiveness of the treatment and improves therapeutic outcomes.

Some drug delivery systems, such as sustained-release formulations, enable a slow and controlled release of medication over an extended period. This reduces the frequency of dosing and helps maintain consistent therapeutic levels in the body.

The market report finds that the COVID-19 pandemic positively impacted the drug delivery systems market. Several studies have highlighted the potential of advanced drug delivery systems in developing improved dosage forms for existing therapeutic agents.

For example, in June 2020, Chalmers University of Technology, the University of Gothenburg, and AstraZeneca in Sweden formed a collaboration to initiate research on a nasal spray mRNA vaccine for COVID-19. This research purpose was to create a biomimetic nanoparticle comprised of immune boosters and a targeting protein to establish effective design principles for the immunization of nasal. The research garnered support from various acclaimed healthcare establishments.

Drug Delivery Systems Market Dynamics

Get Free Sample Report

Major Drivers

Rising incidence of chronic diseases drives the market. Chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory disorders are prevalent in different age groups, most commonly in adults and geriatric populations across the world. These conditions require long-term and effective drug therapies, which can be facilitated by advanced drug delivery systems.

Growing demand for self-administration and home healthcare is another major factor driving the drug delivery systems market. There is a growing preference for the self-administration of medications and the delivery of healthcare services in home settings for injuries. Drug delivery systems offer convenience, ease of use, and improved patient compliance.

Existing Restraints

High cost of developing and commercializing drug delivery systems is hampering the market. Drug delivery system involves significant research and designing, testing, and obtaining clinical data to demonstrate safety and efficacy requires substantial investments. The high costs associated with development can limit the entry of smaller companies or startups into the market.

Major Opportunities

Rising awareness about personalized medicine creates lucrative opportunities for the market. The concept of personalized medicine is gaining momentum, and drug delivery systems play a crucial role in its implementation. Customized medication delivery based on individual patient characteristics, such as genetic profile or disease stage, can lead to more effective and personalized treatments.

Scope of the Drug Delivery Systems Market Report

The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Based on the delivery system, the drug delivery systems market is divided into targeted drug delivery, pro-drug impacts, polymeric drug delivery, and intra uterine. The targeted drug delivery segment is expected to expand at a robust growth rate during the projection period due to the growing nanotechnology application in healthcare treatments.

Some drug delivery systems are designed to specifically target certain tissues, cells, or organs within the body. These systems use various approaches, such as nanoparticles, liposomes, or antibodies, to deliver drugs to specific locations, reducing side effects and improving therapeutic efficacy. Using imaging and diagnostics technology professionals can track liposomes within the body in real-time.

Get Free Sample Report

On the basis of the route of administration, the global market is segregated into oral, injectable, topical, transdermal, inhalation, pulmonary, nasal, and ocular. The oral segment is projected to register a considerable CAGR during the forecast period due to the increasing popularity of biopharmaceutical drugs in tablet and capsule forms.

Oral drug delivery is widely recognized as the most convenient and prevalent method of administering medications worldwide. It offers numerous advantages such as being non-invasive, cost-effective, painless, and easily self-administered, without the need for sterile precautions.

The introduction of innovative drugs that offer effective treatment for various non-communicable diseases (NCDs) with minimal or without any side effects is playing a key role in driving the expansion of oral drug delivery. This approach is particularly valuable in cancer therapies, where targeted drug carriers or nanoparticles are used to deliver chemotherapy directly to tumor cells while sparing healthy tissues.

On the basis of application, the drug delivery systems market is segmented into cancer, diabetes, urology, respiratory, cardiovascular, and central nervous systems. The cancer segment is expected to witness a substantial growth rate during the forecast period due to the increasing advanced cancer diagnostics preference in the population. The emerging technology solutions in the cancer field have contributed to the growing importance of the topical route of administration.

According to the International Agency for Research on Cancer, there were approximately 19.3 million new cancer cases and 10 million cancer-related deaths worldwide in 2020. Furthermore, global cancer cases are projected to increase by 47% from 2020 to 2040, with an estimated 28.4 million cases in 2040.

Prominent types of cancer that significantly affect individuals health worldwide include breast cancer, lung cancer, colorectal cancer, and uterine cancer. As a result, the need for effective topical treatments has become more significant in managing and treating these types of cancer.

The cardiovascular segment is projected to experience rapid growth in the coming years, due to global pharmaceutical companies increasing focus on developing drugs for the treatment of cardiovascular diseases. Unhealthy food habits, rising obesity rates, increased alcohol consumption, and sedentary lifestyles are contributing to a higher prevalence of cardiovascular diseases.

Consequently, there has been a significant increase in the number of deaths related to cardiovascular diseases. In fact, according to the World Health Organization, cardiovascular diseases accounted for 32% of global deaths in 2019. This has created a demand for effective medications and therapies, leading to the accelerated growth of the cardiovascular segment in the pharmaceutical industry.

Get Free Sample Report

Based on the end-user the drug delivery systems market is segregated into hospitals, home care, and clinics. The hospitals segment is expected to hold a major market share during the forecast period, due to the widespread presence of private and public hospitals globally.

Worldwide, various governments and the corporate sector are making significant investments in developing advanced healthcare facilities. Additionally, the increasing burden of diseases and subsequent rise in hospital admissions have contributed to the expansion of hospitals worldwide. These factors have collectively driven the demand for drug delivery systems in hospitals and solidified their position in the healthcare industry.

Regional Outlook

In terms of region, the global drug delivery systems market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to increasing investment in research and development (R&D) associated with advanced medication delivery systems.

Additionally, in the region, there are several factors, including the growing incidence of chronic ailments such as cancer, respiratory allergies, and diabetes driving the need for innovative drug delivery systems. Furthermore, a growing trend of patients embracing advanced drug delivery technologies propelling the market in the region.

The Asia Pacific region is expected to grow rapidly in the global drug delivery systems market due to the increasing prevalence of chronic diseases in the population. These diseases are increasing due to factors such as rising sedentary lifestyles, physical inactivity, and unhealthy dietary habits. The growing availability of advanced drug delivery systems in the region is providing improved access to medical care for the population in the region.

The region has witnessed rapid growth in the biotechnology sector, leading to a higher demand for biotechnology drugs. As per the World Health Organization, a significant number of deaths due to chronic diseases occur in low and middle-income countries. Therefore, the improved accessibility to healthcare facilities in the region is driving the market.

Get Free Sample Report